0001209191-21-028854.txt : 20210428
0001209191-21-028854.hdr.sgml : 20210428
20210428203550
ACCESSION NUMBER: 0001209191-21-028854
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210426
FILED AS OF DATE: 20210428
DATE AS OF CHANGE: 20210428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Richardson Peter C
CENTRAL INDEX KEY: 0001343502
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 21866590
MAIL ADDRESS:
STREET 1: 28903 NORTH AVENUE PAINE
CITY: VALENCIA
STATE: CA
ZIP: 91355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-04-26
1
0001016169
ANTARES PHARMA, INC.
ATRS
0001343502
Richardson Peter C
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
0
1
0
0
EVP, R&D Chief Medical Officer
No securities beneficially owned.
Lisa M. Kallebo as attorney-in-fact for Peter C. Richardson
2021-04-28
EX-24.3_981319
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that I, Dr. Peter Richardson, hereby
constitute and appoint Fred M. Powell, Peter J. Graham, Lisa M. Kallebo and
Keith Muckenhirn, each of them, my true and lawful attorneys-in-fact and agents,
each acting alone, with full powers of substitution and resubstitution for me
and in my name, place and stead, to sign any reports on Form 3 (Initial
Statement of Beneficial Ownership), Form 4 (Statement of Changes in Beneficial
Ownership of Securities) and Form 5 (Annual Statement of Changes in Beneficial
Ownership) relating to transactions by me in Common Stock or other securities of
Antares Pharma, Inc., and all amendments thereto, and to file the same with the
Securities and Exchange Commission and appropriate securities listing agency, if
required, granting unto said attorneys-in-fact and agents, and each of them, or
their substitutes, full power and authority to do and perform each and every act
and thing requisite or necessary to be done, as fully to all intents and
purposes as I might or could do in person, hereby ratifying and confirming all
that said attorneys-in-fact and agents, and each of them, or their substitutes,
may lawfully do or cause to be done by virtue hereof. This Power of Attorney
shall be effective until such time as I deliver a written revocation thereof to
my above-named attorneys-in-fact and agents.
Signed: /s/ Peter C. Richardson
Dated: April 22,2021